Suzhou gutechnetium: the controlling shareholder completed the reduction of 3% shares

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

China Eastern Airlines Receives USD 1.1 Bn Orders in the Third CIIE

The company received orders from CFM International, Honeywell International, and other 21 leading international manufacturers from 11 countries and regions in the third CIIE.

Bad Quarter for Leading Chinese Airlines – China Southern Alone Shows Profits for Q3 2020

The three major China airlines have notified investors that the financial performance of the whole year 2020 may be seriously affected by the spread of COVID-19. Only China Southern had a positive update to share.

Price of Eyebright, the First Star Market-listed Ophthalmic Device, Rises over 500% on IPO

Eyebright (688050) landed on the Chinese Nasdaq as the first ophthalmic device maker.

Aier Eye – the Largest Ophthalmology Hospital Chain in China

With an aging Chinese population and the rising addiction to electronics, ophthalmological medical institutions are faced with enhanced demand.